Avecho Biotechnology Limited
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its hum… Read more
Avecho Biotechnology Limited (AVEFF) - Total Liabilities
Latest total liabilities as of June 2025: $6.37 Million USD
Based on the latest financial reports, Avecho Biotechnology Limited (AVEFF) has total liabilities worth $6.37 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avecho Biotechnology Limited - Total Liabilities Trend (1993–2024)
This chart illustrates how Avecho Biotechnology Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Avecho Biotechnology Limited Competitors by Total Liabilities
The table below lists competitors of Avecho Biotechnology Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Madusari Murni Indah Tbk PT
JK:MOLI
|
Indonesia | Rp421.88 Billion |
|
Gateway Real Estate AG
XETRA:GTY
|
Germany | €1.18 Billion |
|
Transatlantic Mining Corp
PINK:TRRGF
|
USA | $5.28 Million |
|
Zena Mining Corp
V:ZCC-H
|
Canada | CA$33.30K |
|
IT Tech Packaging Inc
NYSE MKT:ITP
|
USA | $23.65 Million |
|
Asuransi Dayin Mitra Tbk
JK:ASDM
|
Indonesia | Rp389.61 Billion |
|
AlphaTON Capital Corp.
NASDAQ:ATON
|
USA | $21.70 Million |
|
Investsmart Group Ltd
AU:INV
|
Australia | AU$6.41 Million |
Liability Composition Analysis (1993–2024)
This chart breaks down Avecho Biotechnology Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 7.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avecho Biotechnology Limited (1993–2024)
The table below shows the annual total liabilities of Avecho Biotechnology Limited from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.73 Million | +83.43% |
| 2023-12-31 | $941.54K | +2.27% |
| 2022-12-31 | $920.66K | +29.79% |
| 2021-12-31 | $709.36K | +1.31% |
| 2020-12-31 | $700.17K | +25.90% |
| 2019-12-31 | $556.12K | -38.35% |
| 2018-12-31 | $902.04K | -50.87% |
| 2017-12-31 | $1.84 Million | +7.57% |
| 2016-12-31 | $1.71 Million | -6.00% |
| 2015-12-31 | $1.82 Million | -3.04% |
| 2014-12-31 | $1.87 Million | -14.36% |
| 2013-12-31 | $2.19 Million | +44.93% |
| 2012-12-31 | $1.51 Million | -58.44% |
| 2011-12-31 | $3.63 Million | -75.40% |
| 2010-12-31 | $14.76 Million | -15.04% |
| 2009-12-31 | $17.38 Million | -1.48% |
| 2008-12-31 | $17.64 Million | -53.29% |
| 2007-12-31 | $37.76 Million | -0.69% |
| 2006-12-31 | $38.02 Million | -2.35% |
| 2005-12-31 | $38.94 Million | +4702.46% |
| 2004-12-31 | $810.73K | +3127.69% |
| 2003-12-31 | $25.12K | -17.24% |
| 2002-12-31 | $30.35K | -46.21% |
| 2001-12-31 | $56.42K | -69.54% |
| 2000-12-31 | $185.25K | +156.71% |
| 1999-12-31 | $72.16K | +117.59% |
| 1998-12-31 | $33.16K | -54.87% |
| 1997-12-31 | $73.48K | -98.74% |
| 1996-12-31 | $5.84 Million | +4.60% |
| 1995-12-31 | $5.58 Million | +1368.16% |
| 1994-12-31 | $380.00K | -73.95% |
| 1993-12-31 | $1.46 Million | -- |